Jaguar Health, Inc. Quarterly Amortization of Intangible Assets in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Jaguar Health, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2017 to Q3 2024.
  • Jaguar Health, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $461K, a 5.73% decline year-over-year.
  • Jaguar Health, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $1.92M, a 1.18% decline year-over-year.
  • Jaguar Health, Inc. annual Amortization of Intangible Assets for 2023 was $2M, a 11.1% increase from 2022.
  • Jaguar Health, Inc. annual Amortization of Intangible Assets for 2022 was $1.8M, a 5.88% increase from 2021.
  • Jaguar Health, Inc. annual Amortization of Intangible Assets for 2021 was $1.7M, unchanged from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.92M $461K -$28K -5.73% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $1.95M $434K -$54K -11.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $2M $489K +$1K +0.21% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2M $535K +$58K +12.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $1.94M $489K +$6K +1.24% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $1.94M $488K +$66K +15.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $1.87M $488K +$70K +16.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $1.8M $477K +$43K +9.91% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $1.76M $483K +$61K +14.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $1.7M $422K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $1.7M $418K -$4K -0.95% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $1.7M $434K $0 0% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 $1.7M $422K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1.7M $422K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-22
Q1 2021 $1.7M $422K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $1.7M $434K +$1.26M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $436K $422K -$843K -66.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-17
Q2 2020 $1.28M $422K -$421K -49.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $1.7M $422K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $1.7M -$830K -$830K -7545355% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $2.53M $1.27M +$843K +200% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $1.69M $843K -$334 -0.04% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $1.69M $422K +$333 +0.08% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $1.69M -$11 -$422K -100% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-03
Q3 2018 $2.11M $422K +$141K +50% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $1.97M $843K +$843K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $1.12M $422K +$422K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-21
Q4 2017 $703K $422K Oct 1, 2017 Dec 31, 2017 10-K 2019-04-10
Q3 2017 $281K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-19
Q2 2017 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.